全球靜脈輸液泵市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023至2030年預測

預計到2030年，全球靜脈輸液泵市場需求將從2022年的85.2億美元增至188.3億美元，2023-2030年的複合年成長率為10.42%。

靜脈輸液泵是一種醫療設備，用於通過靜脈將液體、藥物和營養物質直接輸送到患者的血液中。這些設備通常用於醫院、診所和其他醫療機構，在設定的時間內輸送精確、可控量的液體或藥物。靜脈輸液泵旨在精確控制液體或藥物進入患者血液的流速。它們通常由一個泵裝置、一個液體或藥物儲存器以及一個通過靜脈導管連接到患者靜脈的輸液系統組成。這些泵可以通過編程在設定的時間內輸送特定容量的液體或藥物，從而實現精確的劑量和輸送。它們通常用於靜脈注射抗生素、化療藥物和其他需要控制和精確給藥的藥物。靜脈輸液泵還可能具有其它功能，如檢測管道中的氣泡或同時輸送多種藥物。有些型號還可以是攜帶式或穿戴式式的，使患者可以在家中或外出時接受治療。

市場動態：

隨著全球人口老齡化以及癌症、糖尿病和心血管疾病等慢性病發病率的不斷上升，預計對靜脈輸液泵的需求將增加。這些泵通常用於向慢性病患者輸送藥物和液體，隨著慢性病患者人數的增加，對輸液泵的需求也將增加。新型和創新的靜脈輸液泵更加精確、可靠和方便用戶使用。這些泵通常包括無線連接、觸控螢幕界面、自動監測和警報等功能，使其更易於使用，並提高了患者安全性。隨著醫療成本的持續上升和醫院尋求降低再入院率的方法，對家庭醫療保健服務的需求日益成長。靜脈輸液泵是許多家庭醫療保健治療的重要組成部分，因為患者可以在家中接受藥物治療和輸液，而無需前往醫院或診所。全球外科手術數量不斷增加，推動了對靜脈輸液泵的需求。這些泵通常在手術過程中用於輸送麻醉藥和其它藥物，隨著手術數量的增加，對輸液泵的需求也將增加。在許多國家，醫療系統為使用靜脈輸液泵提供報銷，這有助於推動對這些設備的需求。報銷政策因國家和輸液泵類型而異，但總體而言，有利的政策有望促進市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰了解行業結構，評估全球競爭吸引力。此外，這些工具還對全球靜脈輸液泵市場的各個細分市場進行了全面評估。靜脈輸液泵行業的成長和趨勢為本研究提供了整體方法。

市場細分：

靜脈輸液泵市場報告的這一部分提供了國家和地區層面細分市場的詳細數據，從而幫助戰略家確定相應產品或服務的目標人群以及即將到來的機會。

按產品分類

• 容積式輸液泵
• 胰島素輸注泵
• 注射器輸注泵
• 腸內輸注泵
• 非臥床輸注泵
• 患者控制鎮痛（PCA）
• 植入式輸注泵
• 其他

按疾病分類

• 化療
• 糖尿病
• 胃腸病學
• 鎮痛/疼痛管理
• 兒科/新生兒科
• 血液科
• 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太、拉丁美洲、中東和非洲地區靜脈輸液泵市場的當前和未來需求。此外，報告還重點介紹了所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場中主要企業的綜合概況以及全球競爭格局的深入分析。靜脈輸液泵市場的主要參與者包括百特國際公司、博朗梅爾松根公司、美敦力公司、麥瑞醫療設備公司、波士頓科學公司、CareFusion公司、費森尤斯卡比公司、史密斯醫療公司、霍夫曼拉羅氏公司、Tandem糖尿病護理公司、泰爾茂公司、Mindray公司、穆格公司、IRadimed公司。本部分包括競爭格局的整體視圖，其中包括各種戰略發展，如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品上市和其他發展。

目 錄

第一章：前言

• 報告描述
  • 報告目標
  • 目標受眾
  • 獨特銷售主張（USP）和產品
• 研究範圍
• 研究方法
  • 市場調研流程
  • 市場調研方法

第二章：執行摘要

• 市場亮點
• 全球市場概況

第三章：靜脈輸液泵-行業分析

• 簡介- 市場動態
• 市場驅動因素
• 市場限制因素
• 市場機會
• 行業趨勢
• 波特五力分析
• 市場吸引力分析
  • 按產品分類的市場吸引力分析
  • 按疾病適應症的市場吸引力分析
  • 市場吸引力分析：按地區

第四章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料製造商列表
  • 主要原料價格走勢
• 潛在買家名單
• 行銷管道
  • 直接行銷
  • 間接行銷
  • 行銷管道發展趨勢

第五章：COVID-19疫情影響分析

第六章：全球靜脈輸液泵市場分析：按產品分類

• 產品概述
• 歷史和預測數據
• 按產品分析
• 容積式輸注泵
• 胰島素輸注泵
• 注射器輸注泵
• 腸內輸注泵
• 非臥床輸注泵
• 患者控制鎮痛（PCA）
• 植入式輸注泵
• 其他輸液泵

第七章：全球靜脈輸液泵市場分析：按疾病適應症分類

• 疾病適應症概述
• 歷史和預測數據
• 按疾病適應症分析
• 化療
• 糖尿病
• 胃腸病學
• 鎮痛/疼痛管理
• 兒科/新生兒科
• 血液科
• 其他

第八章：全球靜脈輸液泵市場分析：按地區分類

• 地區展望
• 區域概況
• 北美銷售分析
  • 概述、歷史和預測銷售分析
  • 北美細分市場銷售分析
  • 北美地區各國銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概述、歷史和預測銷售分析
  • 歐洲銷售分析
  • 歐洲各國銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概述、歷史和預測銷售分析
  • 亞太地區各細分市場銷售分析
  • 亞太地區各國銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳大利亞銷售分析
  • 亞太其他地區銷售分析
• 拉丁美洲銷售分析
  • 概述、歷史和預測銷售分析
  • 拉丁美洲各細分市場銷售分析
  • 拉丁美洲各國銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概述、歷史和預測銷售分析
  • 中東和非洲各細分市場銷售分析
  • 中東和非洲國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東及非洲其他地區銷售分析

第九章: 靜脈輸液泵企業競爭格局

• 靜脈輸液泵市場競爭格局
• 夥伴關係/合作/協議
• 合併與收購
• 新產品上市
• 其他發展

第10章: 公司簡介

• 頂級公司市場佔有率分析
• 市場集中度
• Baxter International
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• B. Braun Melsungen AG
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Medtronic
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Micrel Medical Devices SA
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Boston Scientific Corporation
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• CareFusion Corporation
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Fresenius Kabi
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Smiths Medical
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• F. Hoffmann-La Roche Ltd.
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Tandem Diabetes Care Inc.
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Terumo Corporation
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Mindray
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• Moog Inc.
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展
• IRadimed Corporation
  • 公司概況
  • 公司收入
  • 產品
  • 近期發展

*注：在公司概況中，財務細節和近期發展取決於可用性，如果是私營公司，則可能不包括在內。

The global demand for Intravenous Infusion Pump Market is presumed to reach the market size of nearly USD 18.83 BN by 2030 from USD 8.52 BN in 2022 with a CAGR of 10.42% under the study period 2023 - 2030.

An intravenous infusion pump is a medical device used to deliver fluids, medications, and nutrients directly into a patient's bloodstream through a vein. These devices are typically used in hospitals, clinics, and other healthcare settings to deliver a precise and controlled amount of fluids or medications over a set period of time. Intravenous infusion pumps are designed to accurately control the flow rate of fluids or medications into the patient's bloodstream. They typically consist of a pump mechanism, a reservoir for the fluid or medication, and a delivery system that is connected to the patient's vein through an intravenous catheter. These pumps can be programmed to deliver a specific volume of fluid or medication over a set period of time, allowing for precise dosing and delivery. They are commonly used to administer intravenous antibiotics, chemotherapy drugs, and other medications that require a controlled and precise delivery. Intravenous infusion pumps may also have additional features, such as the ability to detect air bubbles in the tubing or to deliver multiple medications simultaneously. Some models may also be portable or wearable, allowing patients to receive treatment at home or while on the go.

Market Dynamics:

As the global population ages and the incidence of diseases which are chronic in nature, such as cancer, diabetes, and cardiovascular disease, continues to rise, the demand for intravenous infusion pumps is expected to increase. These pumps are commonly used to deliver medications and fluids to patients with chronic conditions, and as the number of people with these conditions increases, so too will the demand for infusion pumps. New and innovative intravenous infusion pumps that are more accurate, reliable, and user-friendly. These pumps often include features such as wireless connectivity, touchscreen interfaces, and automated monitoring and alerts, which make them easier to use and improve patient safety. As healthcare costs continue to rise and hospitals look for ways to reduce readmissions, there is a growing demand for home healthcare services. Intravenous infusion pumps are an important component of many home healthcare treatments, as they allow patients to receive medication and fluids at home without needing to visit a hospital or clinic. The number of surgical procedures being performed globally is on the rise, driving the demand for intravenous infusion pumps. These pumps are commonly used during surgery to deliver anaesthesia and other medications, and as the number of surgical procedures increases, so too will the demand for infusion pumps. In many countries, healthcare systems provide reimbursement for the use of intravenous infusion pumps, which helps to drive demand for these devices. Reimbursement policies vary by country and by type of infusion pump, but in general, favourable policies are expected to assist the growth of the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of intravenous infusion pump. The growth and trends of intravenous infusion pump industry provide a holistic approach to this study.

Market Segmentation:

This section of the intravenous infusion pump market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Volumetric Infusion Pumps
• Insulin Infusion Pumps
• Syringe Infusion Pumps
• Enteral Infusion Pumps
• Ambulatory Infusion Pumps
• Patient Controlled Analgesia (PCA)
• Implantable Infusion Pumps
• Others

By Disease Indication

• Chemotherapy
• Diabetes
• Gastroenterology
• Analgesia/Pain Management
• Pediatrics/Neonatology
• Hematology
• Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Intravenous Infusion Pump market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the intravenous infusion pump market include Baxter International, B. Braun Melsungen AG, Medtronic, Micrel Medical Devices SA, Boston Scientific Corporation, CareFusion Corporation, Fresenius Kabi, Smiths Medical, F. Hoffmann-La Roche Ltd., Tandem Diabetes Care Inc., Terumo Corporation, Mindray, Moog Inc., IRadimed Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . INTRAVENOUS INFUSION PUMP - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Disease Indication
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL INTRAVENOUS INFUSION PUMP MARKET ANALYSIS BY PRODUCT

• 6.1 Overview by Product
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Product
• 6.4 Volumetric Infusion Pumps Historic and Forecast Sales by Regions
• 6.5 Insulin Infusion Pumps Historic and Forecast Sales by Regions
• 6.6 Syringe Infusion Pumps Historic and Forecast Sales by Regions
• 6.7 Enteral Infusion Pumps Historic and Forecast Sales by Regions
• 6.8 Ambulatory Infusion Pumps Historic and Forecast Sales by Regions
• 6.9 Patient Controlled Analgesia (PCA) Historic and Forecast Sales by Regions
• 6.10. Implantable Infusion Pumps Historic and Forecast Sales by Regions
• 6.11 Others Historic and Forecast Sales by Regions

7 . GLOBAL INTRAVENOUS INFUSION PUMP MARKET ANALYSIS BY DISEASE INDICATION

• 7.1 Overview by Disease Indication
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Disease Indication
• 7.4 Chemotherapy Historic and Forecast Sales by Regions
• 7.5 Diabetes Historic and Forecast Sales by Regions
• 7.6 Gastroenterology Historic and Forecast Sales by Regions
• 7.7 Analgesia/Pain Management Historic and Forecast Sales by Regions
• 7.8 Pediatrics/Neonatology Historic and Forecast Sales by Regions
• 7.9 Hematology Historic and Forecast Sales by Regions
• 7.10. Others Historic and Forecast Sales by Regions

8 . GLOBAL INTRAVENOUS INFUSION PUMP MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE INTRAVENOUS INFUSION PUMP COMPANIES

• 9.1. Intravenous Infusion Pump Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF INTRAVENOUS INFUSION PUMP INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Baxter International
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. B. Braun Melsungen AG
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Medtronic
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Micrel Medical Devices SA
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Boston Scientific Corporation
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. CareFusion Corporation
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Fresenius Kabi
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. Smiths Medical
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. F. Hoffmann-La Roche Ltd.
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. Tandem Diabetes Care Inc.
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments
• 10.13. Terumo Corporation
  • 10.13.1. Company Overview
  • 10.13.2. Company Revenue
  • 10.13.3. Products
  • 10.13.4. Recent Developments
• 10.14. Mindray
  • 10.14.1. Company Overview
  • 10.14.2. Company Revenue
  • 10.14.3. Products
  • 10.14.4. Recent Developments
• 10.15. Moog Inc.
  • 10.15.1. Company Overview
  • 10.15.2. Company Revenue
  • 10.15.3. Products
  • 10.15.4. Recent Developments
• 10.16. IRadimed Corporation
  • 10.16.1. Company Overview
  • 10.16.2. Company Revenue
  • 10.16.3. Products
  • 10.16.4. Recent Developments

 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

•  Market Snapshot
•  Drivers : Impact Analysis
•  Restraints : Impact Analysis
•  List of Raw Material
•  List of Raw Material Manufactures
•  List of Potential Buyers
•  Analysis by Product (USD MN)
•  Volumetric Infusion Pumps Market Sales by Geography (USD MN)
•  Insulin Infusion Pumps Market Sales by Geography (USD MN)
•  Syringe Infusion Pumps Market Sales by Geography (USD MN)
•  Enteral Infusion Pumps Market Sales by Geography (USD MN)
•  Ambulatory Infusion Pumps Market Sales by Geography (USD MN)
•  Patient Controlled Analgesia (PCA) Market Sales by Geography (USD MN)
•  Implantable Infusion Pumps Market Sales by Geography (USD MN)
•  Others Market Sales by Geography (USD MN)
•  Analysis Market by Disease Indication (USD MN)
•  Chemotherapy Market Sales by Geography (USD MN)
•  Diabetes Market Sales by Geography (USD MN)
•  Gastroenterology Market Sales by Geography (USD MN)
•  Analgesia/Pain Management Market Sales by Geography (USD MN)
•  Pediatrics/Neonatology Market Sales by Geography (USD MN)
•  Hematology Market Sales by Geography (USD MN)
•  Others Market Sales by Geography (USD MN)
•  Global Intravenous Infusion Pump Market Sales by Geography (USD MN)
•  North America Market Analysis (USD MN)
•  United State Market Analysis (USD MN)
•  Canada Market Analysis (USD MN)
•  Mexico Market Analysis (USD MN)
•  Europe Market Analysis (USD MN)
•  Europe Market Estimate by Country (USD MN)
•  United Kingdom Market Analysis (USD MN)
•  France Market Analysis (USD MN)
•  Germany Market Analysis (USD MN)
•  Italy Market Analysis (USD MN)
•  Russia Market Analysis (USD MN)
•  Spain Market Analysis (USD MN)
•  Rest of Europe Market Analysis (USD MN)
•  Asia Pacific Market Analysis (USD MN)
•  China Market Analysis (USD MN)
•  Japan Market Analysis (USD MN)
•  India Market Analysis (USD MN)
•  South Korea Market Analysis (USD MN)
•  Australia Market Analysis (USD MN)
•  Rest of Asia Pacific Market Analysis (USD MN)
•  Latin America Market Analysis (USD MN)
•  Brazil Market Analysis (USD MN)
•  Argentina Market Analysis (USD MN)
•  Peru Market Analysis (USD MN)
•  Chile Market Analysis (USD MN)
•  Rest of Latin America Market Analysis (USD MN)
•  Middle East & Africa Market Analysis (USD MN)
•  Saudi Arabia Market Analysis (USD MN)
•  UAE Market Analysis (USD MN)
•  Israel Market Analysis (USD MN)
•  South Africa Market Analysis (USD MN)
•  Rest of Middle East and Africa Market Analysis (USD MN)
•  Partnership/Collaboration/Agreement
•  Mergers And Acquisition

LIST OF FIGURES

•  Research Scope of Intravenous Infusion Pump Report
•  Market Research Process
•  Market Research Methodology
•  Global Intravenous Infusion Pump Market Size, by Region (USD MN)
•  Porters Five Forces Analysis
•  Market Attractiveness Analysis by Product
•  Market Attractiveness Analysis by Disease Indication
•  Market Attractiveness Analysis by Region
•  Value Chain Analysis
•  Global Market Analysis by Product (USD MN)
•  Volumetric Infusion Pumps Market Sales by Geography (USD MN)
•  Insulin Infusion Pumps Market Sales by Geography (USD MN)
•  Syringe Infusion Pumps Market Sales by Geography (USD MN)
•  Enteral Infusion Pumps Market Sales by Geography (USD MN)
•  Ambulatory Infusion Pumps Market Sales by Geography (USD MN)
•  Patient Controlled Analgesia (PCA) Market Sales by Geography (USD MN)
•  Implantable Infusion Pumps Market Sales by Geography (USD MN)
•  Others Market Sales by Geography (USD MN)
•  Global Market Analysis by Disease Indication (USD MN)
•  Chemotherapy Market Sales by Geography (USD MN)
•  Diabetes Market Sales by Geography (USD MN)
•  Gastroenterology Market Sales by Geography (USD MN)
•  Analgesia/Pain Management Market Sales by Geography (USD MN)
•  Pediatrics/Neonatology Market Sales by Geography (USD MN)
•  Hematology Market Sales by Geography (USD MN)
•  Others Market Sales by Geography (USD MN)
•  Global Market by Revenue
•  North America Market by Revenue
•  Europe Market by Revenue
•  Asia Pacific Market by Revenue
•  Latin America Market by Revenue
•  Middle East & Africa Market by Revenue
•  Recent Development in Industry
•  Top Companies Market Share Analysis

 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.